Cargando…
Impaired aspirin-mediated platelet function inhibition in resuscitated patients with acute myocardial infarction treated with therapeutic hypothermia: a prospective, observational, non-randomized single-centre study
The majority of resuscitated patients present with underlying cardiac disease, and out of these myocardial infarction is most common. Immediate interventional treatment is recommended and routinely requires dual antiplatelet therapy including aspirin and a P2Y12-inhibitor. Therapeutic hypothermia or...
Autores principales: | Prüller, Florian, Milke, Oliver Leopold, Bis, Lukasz, Fruhwald, Friedrich, Scherr, Daniel, Eller, Philipp, Pätzold, Sascha, Altmanninger-Sock, Siegfried, Rainer, Peter, Siller-Matula, Jolanta, von Lewinski, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821616/ https://www.ncbi.nlm.nih.gov/pubmed/29468430 http://dx.doi.org/10.1186/s13613-018-0366-x |
Ejemplares similares
-
Cangrelor Induces More Potent Platelet Inhibition without Increasing Bleeding in Resuscitated Patients
por: Prüller, Florian, et al.
Publicado: (2018) -
PRospective REgistry of PAtients in REfractory cardiogenic shock—The PREPARE CardShock registry
por: von Lewinski, Dirk, et al.
Publicado: (2022) -
Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study
por: Winter, Max-Paul, et al.
Publicado: (2019) -
Platelet reactivity patterns in patients treated with dual antiplatelet therapy
por: Winter, Max‐Paul, et al.
Publicado: (2019) -
Ticagrelor and prasugrel are independent predictors of improved long‐term survival in ACS patients
por: Gager, Gloria M., et al.
Publicado: (2020)